Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tracon Pharmaceuticals
Biotech
Tracon winds down weeks after injectable PD-L1 inhibitor fails
Tracon is winding down operations weeks after an injectable immune checkpoint inhibitor licensed from China flunked a pivotal trial in a rare cancer.
James Waldron
Jul 31, 2024 9:01am
Tracon slips as brain cancer trial misses the mark
Feb 10, 2017 6:40am
J&J invests in, licenses oncology candidates to microcap Tracon
Sep 28, 2016 9:59am